Variations in genes involved in brain signaling pathways appear to be linked to attention-deficit/hyperactivity disorder (ADHD), according to a new study. The findings suggest that drugs that act on these pathways may offer a new treatment option for ADHD patients with the gene variants, the Children’s Hospital of Philadelphia researchers said.
